Aromatase deficiency, and therefore the absence of local estrogen and failure to activate ERβ, locally and within the tissue itself, will result in the development of prostatic hyperplasia and is independent of the systemic hormone status. This evidence concerns the gene CYP19A1 and benign prostatic hyperplasia.